<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-04</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-04</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>118</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>3</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­è”åˆç–—æ³•åœ¨è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„åº”ç”¨å–å¾—è¿›å±•ï¼›ä¸€é¡¹ç ”ç©¶æ­ç¤ºäº†è‚¥èƒ–é©±åŠ¨çš„ç‚ç—‡ä¸ä¸‰é˜´æ€§ä¹³è…ºç™Œè¿›å±•åŠå…ç–«æŠ‘åˆ¶çš„å…³è”ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆTMEï¼‰é‡å¡‘ä¸å…ç–«æ²»ç–—å“åº”ï¼šç ”ç©¶å…³æ³¨å·¨å™¬ç»†èƒæåŒ–ã€ä¸‰çº§æ·‹å·´ç»“æ„ã€ç¥ç»æŸä¼¤åŠè‚¥èƒ–å¯¹TMEå†…å…ç–«ç»†èƒåŠŸèƒ½çš„å½±å“ï¼Œä»¥åŠå…¶åœ¨ç™Œç—‡æ²»ç–—ä¸­çš„ä½œç”¨ã€‚<br />
- è‚¿ç˜¤ä»£è°¢é‡ç¼–ç¨‹ä¸æ²»ç–—è€è¯ï¼šé‡ç‚¹æ¢ç´¢èµ–æ°¨é…¸ã€ä¸é…¸ç›ç­‰ä»£è°¢äº§ç‰©ä»¥åŠKEAP1-NRF2ç³»ç»Ÿå’Œm6Aä¿®é¥°åœ¨è‚¿ç˜¤è¿›å±•ã€æ²»ç–—è€è¯ï¼ˆå¦‚æ–°è¾…åŠ©åŒ–ç–—ã€é¡ºé“‚ã€å¤šè¥¿ä»–èµ›ï¼‰ä¸­çš„ä½œç”¨ã€‚<br />
- å…ç–«ç»†èƒä¸è‚¿ç˜¤ç›¸äº’ä½œç”¨ï¼šåˆ†æTç»†èƒåœ¨è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„è¡Œä¸ºï¼Œä»¥åŠå…¶ä¸å·¨å™¬ç»†èƒã€ä¸Šçš®ç»†èƒç­‰åœ¨ä¸åŒç™Œç—‡ç±»å‹ï¼ˆå¦‚ä¹³è…ºç™Œã€è‚ç™Œã€åµå·¢ç™Œï¼‰ä¸­çš„ååŒæˆ–æ‹®æŠ—ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-Seqï¼‰å’Œç©ºé—´è½¬å½•ç»„å­¦ï¼ˆSpatial Transcriptomicsï¼‰åœ¨è§£æè‚¿ç˜¤å¾®ç¯å¢ƒå¼‚è´¨æ€§åŠç»†èƒé—´ç›¸äº’ä½œç”¨æ–¹é¢çš„å¹¿æ³›åº”ç”¨ã€‚<br />
- é•¿è¯»é•¿æµ‹åºï¼ˆLong-Read Sequencingï¼‰å’Œå…¨åŸºå› ç»„æµ‹åºåœ¨æ­ç¤ºè‚¿ç˜¤åŸºå› ç»„ç‰¹å¾å’Œè½¬å½•ç»„/è›‹ç™½è´¨ç»„è°±ä¸­çš„åˆ›æ–°åº”ç”¨ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
äººå·¥æ™ºèƒ½åœ¨ç”Ÿæˆç²¾å‡†è‚¿ç˜¤æ´å¯Ÿæ–¹é¢æ—¥ç›Šæ™®åŠï¼Œä»¥åŠåŸºäºè¡€æ¶²çš„ç™Œç—‡æ—©æœŸæ£€æµ‹æ–¹æ³•çš„å‡ºç°ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- å¼€å‘é’ˆå¯¹ä¸­æ¢ç¥ç»ç³»ç»Ÿæ¶æ€§è‚¿ç˜¤æ‚£è€…çš„CAR Tç»†èƒç–—æ³•ã€‚<br />
- æ¨è¿›ç²¾å‡†è‚¿ç˜¤å­¦ï¼Œå…³æ³¨æ–°è¯é€‚åº”ç—‡è·æ‰¹ã€æ–°å‹è¯ç‰©å¼€å‘ï¼ˆADCã€PROTACsï¼‰ä»¥åŠéä¼ ç»Ÿç”Ÿç‰©æ ‡å¿—ç‰©è¯†åˆ«ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æŒç»­å‘å±•æŠ—ä½“-è¯ç‰©å¶è”ç‰©ï¼ˆADCï¼‰å’Œè›‹ç™½æ°´è§£é¶å‘åµŒåˆä½“ï¼ˆPROTACsï¼‰ã€‚<br />
- äººå·¥æ™ºèƒ½ï¼ˆAIï¼‰åœ¨ç²¾å‡†è‚¿ç˜¤å­¦ä¸­çš„åº”ç”¨æ—¥ç›Šå¹¿æ³›ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç§‘å­¦å®¶å‘ç°ï¼Œä¸€ç§70å¹´å‰çš„è¯ç‰©èƒ½æ¿€æ´»è„‘ç™Œç»†èƒçš„â€œæ°§æ°”è­¦æŠ¥â€ï¼Œæ­ç¤ºå…¶ç”Ÿå­˜æœºåˆ¶ï¼›åŒæ—¶ï¼Œæ–°å‹è®¡ç®—æ–¹æ³•scPERåˆ©ç”¨RNAæµ‹åºæŠ€æœ¯ï¼Œé¦–æ¬¡å®ç°ä»æ•´ä½“RNAæ•°æ®ä¸­è¯†åˆ«è‚¿ç˜¤ç»†èƒäºšç¾¤ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç™Œç—‡ç»†èƒç”Ÿå­˜æœºåˆ¶ä¸æ²»ç–—æ–°é¶ç‚¹å‘ç°ï¼ˆå¦‚è„‘ç™Œã€ä¹³è…ºç™Œï¼‰ã€‚<br />
- è‚ é“èŒç¾¤å¥åº·ä¸æ—¥å¸¸åŒ–å­¦ç‰©è´¨æš´éœ²çš„å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æœºå™¨å­¦ä¹ æ–¹æ³•scPERç”¨äºè‚¿ç˜¤ç»†èƒäºšç¾¤é‰´å®šã€‚<br />
- æ–°å‹æ£€æµ‹æ–¹æ³•QuEChERSç”¨äºé£Ÿå“ä¸­è‡´ç™ŒåŒ–åˆç‰©çš„è¯†åˆ«ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (110æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE305308 å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­è¯±å¯¼å·¨å™¬ç»†èƒé‡æåŒ–ï¼Œè¿›è€Œé©±åŠ¨è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„Tç»†èƒæ´»åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€tumor microenvironmentã€macrophage<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tina Kwok ; Jessica N LancasterSeries Type : Expression profiling by arrayOrganism : Mus musculusImmunotherapy combinations can improve patient outcomes, yet the interactions within the tumor microenvironment (TME) that drive therapeutic synergy are poorly understood. Tumor establishment drives monocyte recruitment and differentiation into tumor-associated macrophages (TAMs), which have essential roles in coordinating immune responses and are thus attractive targets for therapeutic modulation. In a murine model of combination anti-PD-1 and anti-PD-L1 checkpoint blockade, tumor control was associated with increased infiltration of CD8+ T-cells and M1-like repolarization of TAMs. Live-cell imaging of the tumor microenvironment revealed close contacts between tumor-infiltrating CD8+ T-cells and TAMs, in which the extent of the contact interfaces increased with combination immunotherapy. Treatment with anti-PD-L1 was able to increase macrophage expression of pro-inflammatory factors and phagocytic activity, suggesting a role for TAMs in reactivating CD8+ T-cells in the TME. However, co-treatment with anti-PD-1 was ultimately necessary for tumor control, indicating the need for combination targeting of the TME.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305308" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE309004 ä¹³è…ºç™Œæ–°è¾…åŠ©åŒ–ç–—è€è¯æ€§çš„åˆ†å­å†³å®šå› ç´ ï¼šåŸºå› è¡¨è¾¾å’Œè‚¿ç˜¤å¾®ç¯å¢ƒåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€tumor microenvironmentã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hedda M Guevara-Nieto ; Carlos A Orozco ; Rafael Parra Medina ; Jone Garai ; Jovanny Zabaleta ; Liliana Lopez-Kleine ; Alba L CombitaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensNeoadjuvant chemotherapy (NAC) is a critical component of breast cancer treatment, but the molecular mechanisms underlying resistance remain poorly understood. This study aimed to identify transcriptomic changes associated with NAC resistance across four breast cancer subtypes: Luminal A, Luminal B/HER2-positive, Luminal B/HER2-negative, and Triple-Negative Breast Cancer (TNBC). RNA-seq analysis was performed on paired pre- and post-NAC breast cancer samples from 35 non-responders. Differentially expressed genes (DEGs) were identified, and functional enrichment analyses were conducted. Protein-protein interaction (PPI) networks were constructed to identify hub genes. Tumor microenvironment (TME) infiltration was estimated using deconvolution algorithms. The results revealed distinct gene expression profiles between pre- and post-NAC samples, with FOS and NR4A1 being common DEGs across all subtypes. Enriched pathways varied among subtypes, including signal transduction, estrogen biosynthesis, extracellular matrix organization, dendritic cell activation, and B cell activation. TME analysis showed increased infiltration of specific immune cell populations after NAC, including CD4 memory T cells, regulatory T cells, neutrophils, macrophages, and mast cells, varying by subtype. These findings suggest that NAC modulates gene expression, cellular activity, and TME interactions, potentially contributing to treatment resistance. Understanding the molecular determinants of NAC resistance is crucial for developing targeted therapeutic strategies and improving outcomes for breast cancer patients.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309004" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE294999 è‚¥èƒ–é©±åŠ¨çš„ç‚ç—‡é€šè¿‡å…ç–«æŠ‘åˆ¶ä¿ƒè¿›ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„è¿›å±• [scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammationã€regex:immuno(logy|therapy|suppression)ã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Michael F Coleman ; Stephen D HurstingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculuscontrol and obese, C57BL6J mice with or without sulindac treatment were injected with E0771 cells and tumor growth was monitored<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294999" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE272510 èµ–æ°¨é…¸ä»£è°¢é‡ç¼–ç¨‹é‡å¡‘å…ç–«å¾®ç¯å¢ƒå¹¶è¯±å¯¼è‚ç™Œå…ç–«æ²»ç–—è€å—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€metabolismã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xinlan Lu ; Yungang Xu ; Min QiangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensLiver cancer is one of the most common malignant tumors worldwide, and its high aggressiveness and recurrence rate pose a major challenge. Metabolic reprogramming is one of the cancer hallmarks and allows tumor cells to adapt to drastic changes, supporting their rapid growth, survival, and proliferation under various conditions. The metabolic reprogramming of several amino acids within tumors profoundly affects the function of the immune cells. Furthermore, arginine and various other amino acids are now being widely studied as potential targets for anti-tumor therapy. However, the role of lysine metabolic reprogramming in tumors remains largely unexplored. This study aims to reveal the relationship between lysine metabolism reprogramming and the prognosis of liver cancer, the tumor immune microenvironment (TIME), and responses to immunotherapy through multi-omics analysis. Combined transcriptomic and proteomic analyses revealed a significant downregulation of lysine metabolism in tumor tissues against normal tissue adjacent to the tumor from liver cancer patients. Subsequently, we constructed a lysine metabolism score (LM score) based on nine lysine metabolic genes to stratify liver cancer patients into high and low lysine metabolism subtypes. The LM score exhibited potential in predicting both survival and immunotherapy response in liver cancer. Furthermore, significant differences were observed in prognosis, clinical staging, TIME, and immunotherapy outcomes between the subtypes with low and high lysine metabolism. In the subtype of low lysine metabolism, an immunosuppressive TIME predominated, correlating with poorer patient survival and anti-tumor immune responses. In conclusion, we uncover that disturbed lysine metabolism promotes the formation of the immunosuppressive TIME, thereby inducing immunotherapy resistance and advancing liver cancer progression. This provides an effective theoretical reference for elucidating the mechanism of immunotherapy resistance in liver cancer and seeking new therapeutic strategies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272510" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE270678 ä¸åŒé˜¶æ®µçš„ä¸‰çº§æ·‹å·´ç»“æ„è¡¨ç°å‡ºä¸åŒçš„æŠ—è‚¿ç˜¤å…ç–«åŠ› [ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zemin Zhang ; Sen GaoSeries Type : OtherOrganism : Homo sapiensThe tumour microenvironment (TME) is a focal point in cancer immunotherapy: its cellular composition and spatial organisation, especially the distribution of lymphocytes, can affect the clinical outcomes of cancer patients. In addition, the function of a cell differs depending on its spatial location and interaction with neighbouring cells. Here, by integrating single-cell transcriptomics with spatial transcriptomics, we survey how the spatial distribution of different cell types varies across diverse histological regions of gastric cancer. Notably, tertiary lymphoid structures (TLSs), a tissue architecture harbouring lymphocytes more than any other region within the TME, possess great potential in modulating anti-tumorigenic immunity by elevating an array of genes (FDCSP and CCL19) principally involved in lymphocyte recruitment and activation. Our findings advance the understanding of TLSs in contributing to anti-tumorigenic immunity in a spatially resolved context, which could be further leveraged as a predictive marker for immunotherapy response.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270678" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE306904 ç ”ç©¶è¡¨æ˜ï¼Œåœ¨åµå·¢ç™Œå°é¼ æ¨¡å‹ä¸­ï¼ŒPD-1ã€Tim-1 3 å’Œ Lag-3 ä¸‰é‡å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ï¼ˆè€Œéå•ç‹¬é˜»æ–­ PD-1ï¼‰å¯å¢å¼ºè¿‡ç»§æ€§ T ç»†èƒå…ç–«ç–—æ³•çš„ç–—æ•ˆã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€T cellã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Gabriel F Alencar ; Asmaa O Mohamed ; Madison G Burnett ; Samantha Jean ; Anders Nelson ; Yapeng Su ; Valentin Voillet ; Magdalia R Suarez ; Susan Ruskin ; Lam Trieu ; Jennifer L Lam ; Stefan Bekiranov ; Raphael Gottardo ; Philip D Greenberg ; Kristin G AndersonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe five-year survival rate for ovarian cancer patients remains below 50%, underscoring the need for innovative therapies. One promising approach involves engineering T cells to specifically target proteins uniquely overexpressed in tumors, thereby controlling tumor growth without toxicity to healthy tissues. Mesothelin (Msln) contributes to the malignant and invasive phenotype in ovarian cancer and has limited expression in healthy cells, making it a candidate immunotherapy target. Our previous results in a mouse model of ovarian cancer demonstrated that T cells engineered to express a T cell receptor (TCR) targeting Msln (TCRMSLN) mediated therapeutic activity, delaying tumor growth and prolonging mouse survival. However, inhibitory ligands expressed in the tumor microenvironment (TME) interacted with inhibitory receptors on activated T cells, suppressing antitumor function. We hypothesized combining engineered T cells with checkpoint blockade would enhance T cell function in the TME and improve therapeutic efficacy, but administration of mono-specific antibodies targeting individual inhibitory pathways had no significant impact on T cell efficacy. By contrast, the combination of PD-1, Tim-3 and Lag-3 blockade with engineered T cells significantly improved T cell function and overall animal survival relative to treatment with antibody alone or TCRMSLN with singlet or doublet antibody combinations. Single-cell RNA sequencing revealed TCRMSLN T cells treated with the triplet antibody combination increased expression of genes involved in interferon responses and metabolic function, and reduced expression of genes associated with exhaustion. These results suggest that strategies to disrupt multiple inhibitory pathways simultaneously may be necessary for improved adoptive T cell therapy efficacy in patients.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306904" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE306312 å‘¨å›´ç¥ç»æŸä¼¤è¯±å¯¼çš„è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒé‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œçš„å…ç–«é€ƒé€¸</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yongxue Jiang ; Wenfeng Zeng ; Xiaoting Deng ; Jianing Chen ; Penghan HuangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPeripheral nerve damage is intricately linked to the progression of various solid tumors and play a pivotal role in the tumor ecosystem. However, its effect on antitumor immunity and precise underlying mechanisms remain poorly understood. This study aimed to elucidate the effect of peripheral nerve damage and subsequent immune modulation on breast cancer progression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306312" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE294944 è‚¥èƒ–é©±åŠ¨çš„ç‚ç—‡é€šè¿‡å…ç–«æŠ‘åˆ¶ä¿ƒè¿›ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„è¿›å±•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammationã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Michael F Coleman ; Stephen D HurstingSeries Type : Expression profiling by arrayOrganism : Mus musculuscontrol and obese, C57BL6J mice with or without sulindac treatment were injected with E0771, metMWntlung, or metMWntliver cells and tumor growth was monitored<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294944" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE294724ï¼šä»ç»“ç›´è‚ è‚¿ç˜¤ä¸­åˆ†ç¦»å‡ºçš„æ–°å‹å£è…”é“¾çƒèŒCRC211èŒæ ªçš„å…¨åŸºå› ç»„æµ‹åºå’Œåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€sequencingã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yunjie Shi ; Ling Liu ; Weiliang Hou ; Hao wangSeries Type : OtherOrganism : Mus musculusThis study provides a comprehensive genomic characterization of Streptococcus oralis CRC211, a novel bacterial strain isolated from colorectal tumor tissue, through whole-genome sequencing and comparative analysis. The high-quality assembled genome (15.03 Mb, 40.94% GC content) contains 2 prophage regions spanning 160.5 kb, which may facilitate horizontal transfer of virulence genes. Functional annotation identified 3,674 genes, with significant enrichment in metabolic pathways (amino acid and carbohydrate metabolism) and virulence factors (116 genes in VFDB), including adhesins and biofilm-associated proteins that likely promote tumor colonization. Comparative genomic analysis revealed CRC211 shares 92.29% average nucleotide identity with reference S. oralis strains, while pan-genome analysis demonstrated an open genome structure with 1,222 conserved core genes. The strain also carries 75 antimicrobial resistance genes, suggesting potential clinical relevance. Notably, the genomic profile indicates adaptations for nutrient acquisition and immune evasion in the tumor microenvironment. These findings establish CRC211 as a CRC-associated strain with distinct genomic features that may contribute to tumor progression, providing crucial insights for future investigations into its oncogenic mechanisms and potential applications in microbiota-based diagnostics or therapeutics for colorectal cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294724" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE293361 æŠ—ç™Œæ²»ç–—è¯±å¯¼çš„KEAP1-NRF2ç³»ç»ŸåŸºå› æ”¹å˜å¯¼è‡´å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œå¯¹é¡ºé“‚äº§ç”Ÿè€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yuki Nakayama ; Keiko Taguchi ; Masayuki YamamotoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCisplatin (CDDP) is widely used in the chemotherapy of head-and-neck squamous cell carcinoma (HNSCC), but its efficacy is limited in recurrent cases. This highlights the need for a deeper understanding of the mechanisms underlying the CDDP resistance. We hypothesized that chemoradiotherapy with CDDP may induce hyperactivation of NRF2, contributing to CDDP resistance. To investigate this, we first examined NRF2 expression in clinical HNSCC samples by immunohistochemistry and assessed the occurrence of somatic mutations in KEAP1 and NRF2 genes using public databases. We found that high NRF2 expression was associated with poorer prognosis compared to low expression. Furthermore, recurrent HNSCC cases following post-operative chemoradiotherapy exhibited higher NRF2 accumulation than their corresponding primary tumors. Database analysis also revealed occurrence of frequent mutations in KEAP1 associated with CDDP treatment. We then assessed the role of NRF2 in HNSCC malignancy utilizing seven parent (P) HNSCC cell lines and their CDDP-resistant (CR) derivatives. Of these P-CR pairs, three CR cell lines exhibited NRF2 upregulation. Two of them carried KEAP1 mutations and one carried an NRF2 mutation, both present in P and CR lines. These NRF2-high CR lines showed elevated expression of NRF2 target gene and activation of xenobiotic metabolism and reactive oxygen species pathways. Treatment with mitomycin C (MMC), known for its synthetic lethal activity against NRF2-activated cancer cells, showed strong cytotoxicity in NRF2-high CR lines. These findings indicate that the KEAP1-NRF2 system plays a critical role in the development of CDDP resistance and that MMC represents a promising therapeutic option for NRF2-high/CDDP-resistant HNSCC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293361" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 100 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>ä¸­æ¢ç¥ç»ç³»ç»Ÿæ¶æ€§è‚¿ç˜¤æ‚£è€… CAR T ç»†èƒçš„å¼€å‘</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€Tç»†èƒã€ç¥ç»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1995735952302125056/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ç²¾å‡†è‚¿ç˜¤å­¦ï¼š2025å¹´å›é¡¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ‘˜è¦ï¼šæœ¬æ–‡è®¨è®ºäº†2025å¹´ç²¾å‡†è‚¿ç˜¤å­¦å–å¾—çš„å…·ä½“è¿›å±•ï¼Œæˆ‘ä»¬è§è¯äº†å¤šé¡¹å·²çŸ¥ç²¾ç»†è‚¿ç˜¤è¯ç‰©çš„æ–°é€‚åº”ç—‡è·æ‰¹ï¼Œä»¥åŠé’ˆå¯¹ç»å…¸é€šè·¯æˆ–æ­¤å‰æ‰€è°“ä¸å¯è¯ç‰©é¶ç‚¹çš„æ–°è¯çš„æ—©æœŸæœ‰å¸Œæœ›æ•°æ®ã€‚æ­¤å¤–ï¼Œæˆ‘ä»¬è§‚å¯Ÿåˆ°æŠ—ä½“-è¯ç‰©å¶è”ç‰©å’Œè›‹ç™½æ°´è§£é¶å‘åµŒåˆä½“çš„æŒç»­å‘å±•ï¼Œå¤šç§åŸºäºè¡€æ¶²çš„ç™Œç—‡æ—©æœŸæ£€æµ‹æ–¹æ³•çš„å‡ºç°ï¼Œéä¼ ç»Ÿç²¾å‡†è‚¿ç˜¤ç”Ÿç‰©æ ‡å¿—ç‰©çš„è¯†åˆ«ï¼Œä»¥åŠäººå·¥æ™ºèƒ½æŠ€æœ¯åœ¨ç”Ÿæˆç²¾å‡†è‚¿ç˜¤æ´å¯Ÿæ–¹é¢çš„æ—¥ç›Šæ™®åŠã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1996028395203440640/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (6æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨6æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>scPERâ€”â€”ä¸€ç§åˆ©ç”¨æ€»RNAæµ‹åºæ•°æ®è¯†åˆ«è‚¿ç˜¤ç»†èƒäºšå‹çš„è®¡ç®—æ–¹æ³•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€sequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers introduce scPER, a machine learning method using RNA sequencing to estimate tumor cell compositions and reveal...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/scper-a-computational-method-to-identify-tumor-cell-subtypes-from-total-rna-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ä½ çš„è‚ é“æ­£åœ¨é­å—æ¯’å®³å—ï¼Ÿç§‘å­¦å®¶æ­ç¤ºæ—¥å¸¸åŒ–å­¦ç‰©è´¨çš„éšç§˜å½±å“ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers discovered that 168 common chemicals can disrupt the growth of beneficial gut bacteria, with some also promoting antibiotic resistance. Many of these substancesâ€”found in food, water, and household itemsâ€”werenâ€™t previously suspected of affecting living organisms. A new machine learning model now predicts which chemicals may harm the microbiome. The findings suggest safety testing must expand to consider gut health.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251202052215.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>åŒ»ç”Ÿå‘ç°ï¼Œå¹´è½»å¥³æ€§ç½¹æ‚£ä¾µè¢­æ€§ä¹³è…ºç™Œçš„æ¯”ä¾‹æ¯”é¢„æœŸæ›´é«˜ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šYounger women are being diagnosed with breast cancer more often than screening guidelines anticipate. Many of these cancers are invasive and harder to treat, especially in those under 40. After analyzing 11 years of data, researchers found that this age group makes up a steady and significant share of diagnoses. The results support a stronger push for earlier risk evaluation.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251201233536.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ç§‘å­¦å®¶å‘ç°ç™Œç»†èƒå­˜æ´»çš„éšè—å¼€å…³</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have found a small but powerful switch inside breast cancer cells that helps them survive stressful conditions. When this switch flips, the cells activate protective programs that make them tougher and faster-growing. The finding reveals how tumors use stress to their benefit. It may open up new possibilities for therapies.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251130205425.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ä¸€é¡¹æ–°ç ”ç©¶åœ¨å¸¸è§é£Ÿç‰©ä¸­å‘ç°äº†ä¸ç™Œç—‡ç›¸å…³çš„åŒ–åˆç‰©</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists have found that common foods can contain hidden contaminants formed during cooking or through environmental exposure. A new testing method called QuEChERS helps identify these chemicals more quickly and with greater ease. The research showed strong accuracy and high sensitivity across multiple food samples. This streamlined approach could improve food safety checks while reducing chemical waste.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251130205423.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>ä¸€ç§å·²æœ‰70å¹´å†å²çš„å¦Šå¨ è¯ç‰©ï¼Œç«Ÿç„¶æ­ç¤ºäº†å…¶åœ¨æ²»ç–—è„‘ç™Œæ–¹é¢çš„ä¸€ä¸ªéšè—å¼±ç‚¹ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have solved the decades-old mystery behind how a common pregnancy drug lowers blood pressure. It turns out the medication blocks a fast-acting â€œoxygen alarmâ€ inside cells. That same alarm helps brain tumors survive, meaning the drug unexpectedly weakens them, too. The discovery could inspire better treatments for both preeclampsia and brain cancer.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251202052234.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>31</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>13</td>
</tr>
<tr>
<td>tumor</td>
<td>12</td>
</tr>
<tr>
<td>immune</td>
<td>8</td>
</tr>
<tr>
<td>sequencing</td>
<td>7</td>
</tr>
<tr>
<td>resistance</td>
<td>7</td>
</tr>
<tr>
<td>scRNA</td>
<td>6</td>
</tr>
<tr>
<td>carcinoma</td>
<td>6</td>
</tr>
<tr>
<td>transcriptome</td>
<td>6</td>
</tr>
<tr>
<td>metabolic</td>
<td>6</td>
</tr>
<tr>
<td>metabolism</td>
<td>6</td>
</tr>
<tr>
<td>methylation</td>
<td>5</td>
</tr>
<tr>
<td>regex:immuno(logy</td>
<td>therapy</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>5</td>
</tr>
<tr>
<td>tumor microenvironment</td>
<td>4</td>
</tr>
<tr>
<td>inflammation</td>
<td>4</td>
</tr>
<tr>
<td>pathway</td>
<td>4</td>
</tr>
<tr>
<td>immunity</td>
<td>4</td>
</tr>
<tr>
<td>histone</td>
<td>3</td>
</tr>
<tr>
<td>single-cell</td>
<td>3</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (100æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290298" target="_blank" rel="noopener noreferrer">GSE290298 è‚ç™Œæ•´åˆåˆ†ææ­ç¤ºèµ–æ°¨é…¸ä»£è°¢é‡ç¼–ç¨‹ä»¥åŠå…·æœ‰ä¸åŒå…ç–«å¾®ç¯å¢ƒå’Œæ²»ç–—ååº”çš„æ‚£è€…åˆ†å±‚ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287023" target="_blank" rel="noopener noreferrer">GSE287023 ä¸é…¸-LncRNALy6C-RUNX3è½´é€šè¿‡NR4A1ä»‹å¯¼çš„ERK1/2/MAPKé€šè·¯å†³å®šè‚ é“é©»ç•™å·¨å™¬ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269680" target="_blank" rel="noopener noreferrer">GSE269680 CDK8 é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒï¼Œä»¥æŠµæŠ—é¶å‘ KRASG12D æŠ‘åˆ¶åœ¨èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­çš„æ²»ç–—æ•ˆæœï¼ˆç©ºé—´ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269679" target="_blank" rel="noopener noreferrer">GSE269679 CDK8 é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒï¼Œä»¥æŠµæŠ—é¶å‘ KRASG12D æŠ‘åˆ¶åœ¨èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­çš„æ²»ç–—æ•ˆæœï¼ˆscRNAï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311391" target="_blank" rel="noopener noreferrer">GSE311391 é•¿è¯»é•¿æµ‹åºå’Œè›‹ç™½è´¨ç»„å­¦æ­ç¤ºå¤šç§åŸå‘æ€§è‚ºç™Œçš„è¡€æ¶²è½¬å½•ç»„å’Œè›‹ç™½è´¨è¡¨è¾¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312287" target="_blank" rel="noopener noreferrer">GSE312287 KMT5Aä»‹å¯¼çš„IRF3ç”²åŸºåŒ–é€šè¿‡å…ç–«æŠ‘åˆ¶ä¿ƒè¿›è‚¿ç˜¤è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291699" target="_blank" rel="noopener noreferrer">GSE291699 åˆ©ç”¨çº³ç±³å­”æµ‹åºæŠ€æœ¯å¯¹äººç±»ç™Œç—‡æ¨¡å‹è¿›è¡ŒtRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308736" target="_blank" rel="noopener noreferrer">GSE308736 å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºé£Ÿç®¡å°ç»†èƒç™Œçš„ä¸Šçš®å’Œå¾®ç¯å¢ƒå¼‚è´¨æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306626" target="_blank" rel="noopener noreferrer">GSE306626 AC16 ç»†èƒä¸­ HMGN3 ChIP-seq å’Œæ•²ä½/æœªæ•²ä½ AC16 ç»†èƒä¸­çš„ Bulk-RNAseq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306057" target="_blank" rel="noopener noreferrer">GSE306057 ALKBH5-IGF2BP2è½´é€šè¿‡m6Aç¨³å®šçš„CLSPN RNAä»‹å¯¼å‰åˆ—è…ºç™Œè¿›å±•å’Œå¤šè¥¿ä»–èµ›è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305604" target="_blank" rel="noopener noreferrer">GSE305604 æ•´åˆ RNA-seq å’Œ LASSO-COX åˆ†ææ­ç¤ºèŠè¯é…šåœ¨å®«é¢ˆç™Œç»†èƒå¢æ®–æŠ‘åˆ¶å’Œå‡‹äº¡è¯±å¯¼ä¸­çš„å…³é”®é¶åŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301169" target="_blank" rel="noopener noreferrer">GSE301169 PURPL åœ¨åŸºå› è¡¨è¾¾çš„è¡¨è§‚é—ä¼ è°ƒæ§ä¸­å‘æŒ¥ä½œç”¨ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298873" target="_blank" rel="noopener noreferrer">GSE298873 é•¿é“¾éç¼–ç RNA RAB30-DTé€šè¿‡å¢å¼ºç™Œç»†èƒå¹²æ€§ä¿ƒè¿›è‚ç»†èƒç™Œçš„è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297402" target="_blank" rel="noopener noreferrer">GSE297402 CD4âº T ç»†èƒå…±åŸ¹å…»åè¡°è€å’Œéè¡°è€ BPH ä¸Šçš®ç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293543" target="_blank" rel="noopener noreferrer">GSE293543 Tç»†èƒä»‹å¯¼çš„SIVå‘ä¸­æ¢ç¥ç»ç³»ç»Ÿæ‰©æ•£ï¼šå•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292898" target="_blank" rel="noopener noreferrer">GSE292898 åˆ©ç”¨å•ç»†èƒ RNA æµ‹åºåˆ†ç¦»å’Œé‰´å®šèƒ°å²›ç›¸å…³ CD45- MHC II ç±»+ ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292744" target="_blank" rel="noopener noreferrer">GSE292744 BRD4 å’Œ MYB æŠ‘åˆ¶å…‹æœ EVI1 é‡æ’æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­çš„ç»´å¥ˆæ‰˜å…‹è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289417" target="_blank" rel="noopener noreferrer">GSE289417 å¹´è½»å’Œè€å¹´éª¨é«“å·¨æ ¸ç»†èƒç¥–ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286926" target="_blank" rel="noopener noreferrer">GSE286926 KAT6A ä¹™é…°åŒ–é€šè¿‡ AMPK ä»‹å¯¼ç”Ÿé•¿å’Œçº¿ç²’ä½“ä»£è°¢çš„ä»£è°¢é€‚åº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285281" target="_blank" rel="noopener noreferrer">GSE285281 è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒæ¥æºçš„ CD8+ å…‹éš†å‹æµ¸æ¶¦è‚¿ç˜¤ç»„ç»‡å¹¶ä»‹å¯¼èƒ¶è´¨æ¯ç»†èƒç˜¤çš„è‚¿ç˜¤æ¶ˆé€€ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284738" target="_blank" rel="noopener noreferrer">GSE284738 LIMCH1é€šè¿‡ä¸Šè°ƒPDL1æŠ‘åˆ¶ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„æŠ—è‚¿ç˜¤å…ç–«</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284606" target="_blank" rel="noopener noreferrer">GSE284606 ç¼ºè¡€é¢„é€‚åº”å‡å¼±äº†ç¼ºè¡€å†çŒæ³¨æ¡ä»¶ä¸‹çš„å¿ƒè‚ŒDNAç”²åŸºåŒ–å¹¶è°ƒèŠ‚äº†å¿ƒè‚Œè½¬å½•ç»„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282028" target="_blank" rel="noopener noreferrer">GSE282028 å¤šç»„å­¦åˆ†ææ•´åˆæ­ç¤ºç»“è‚ ç™Œä¸­æ–°çš„ TRF2-miR-181a-5p-S100A10 è°ƒæ§è½´ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282027" target="_blank" rel="noopener noreferrer">GSE282027 å¤šç»„å­¦åˆ†ææ•´åˆæ­ç¤ºç»“è‚ ç™Œä¸­æ–°çš„ TRF2-miR-181a-5p-S100A10 è°ƒæ§è½´ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268030" target="_blank" rel="noopener noreferrer">GSE268030 è„‚è´¨ä»£è°¢ä¸èŠ‚æ‹å¼å¡åŸ¹ä»–æ»¨å’Œå¡ç‘åˆ©ç å•æŠ—æ²»ç–—èƒƒè‚ é“ç™Œç—‡çš„ç–—æ•ˆç›¸å…³ï¼šä¸€é¡¹æ¢ç´¢æ€§ä¸´åºŠè¯•éªŒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240920" target="_blank" rel="noopener noreferrer">GSE240920 è‡ªå™¬é€šè¿‡è°ƒæ§WNT/DVLä¿¡å·é€šè·¯æ¥è°ƒèŠ‚ç¥ç»å…ƒåˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312272" target="_blank" rel="noopener noreferrer">GSE312272 KDM6BæŠ‘åˆ¶å‰‚å¯è°ƒèŠ‚å•æ ¸ç»†èƒæ´»åŒ–å¹¶å‡è½»å’ªå–¹è«ç‰¹ï¼ˆIMQï¼‰è¯±å¯¼çš„é“¶å±‘ç—…çš®è‚¤ç‚ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311766" target="_blank" rel="noopener noreferrer">GSE311766 RUNX3ï¼Œä¸€ç§å…¨æ–°çš„NKç»†èƒæµ¸æ¶¦ç”Ÿç‰©æ ‡å¿—ç‰©ä»‹å¯¼ç»“ç›´è‚ ç™Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299648" target="_blank" rel="noopener noreferrer">GSE299648 4-ä¹™é…°æ°¨åŸºè’½é…šLT3é€šè¿‡PI3K/AKTå’ŒMAPKé€šè·¯è°ƒèŠ‚æŠ‘åˆ¶ç»“ç›´è‚ ç™Œçš„ç”Ÿé•¿å’Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270680" target="_blank" rel="noopener noreferrer">GSE270680 ä¸åŒé˜¶æ®µçš„ä¸‰çº§æ·‹å·´ç»“æ„è¡¨ç°å‡ºä¸åŒçš„æŠ—è‚¿ç˜¤å…ç–«åŠ› [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270679" target="_blank" rel="noopener noreferrer">GSE270679 ä¸åŒé˜¶æ®µçš„ä¸‰çº§æ·‹å·´ç»“æ„è¡¨ç°å‡ºä¸åŒçš„æŠ—è‚¿ç˜¤å…ç–«åŠ› [bulk RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228185" target="_blank" rel="noopener noreferrer">GSE228185 CSNK1A1é€šè¿‡ç£·é…¸åŒ–ITGB5ï¼Œç ´åEPS15/EGFRå¤åˆç‰©ï¼Œä»è€Œé™ä½è‚ç»†èƒç™Œå¯¹å¤šé¶ç‚¹é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311517" target="_blank" rel="noopener noreferrer">GSE311517 5-ç”²åŸºèƒå˜§å•¶å’Œ5-ç¾Ÿç”²åŸºèƒå˜§å•¶æ˜¯ç»“ç›´è‚ ç™Œæ—©æœŸæ£€æµ‹çš„ååŒç”Ÿç‰©æ ‡å¿—ç‰©</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296777" target="_blank" rel="noopener noreferrer">GSE296777 å“®å–˜å’Œè¿‡æ•åŸºå› èŠ¯ç‰‡ï¼š5å²å„¿ç«¥å£è…”æ‹­å­DNAç”²åŸºåŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295192" target="_blank" rel="noopener noreferrer">GSE295192 ç¾ä¸¸åˆ‡é™¤æœ¯è¯±å¯¼çš„å°é¼ å‰åˆ—è…ºç»†èƒç»„æˆå’ŒåŸºå› è¡¨è¾¾è°ƒæ§çš„æ—¶ç©ºå›¾è°±[scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289750" target="_blank" rel="noopener noreferrer">GSE289750 å±‚ç²˜è›‹ç™½A/C-EZH2ç›¸äº’ä½œç”¨åœ¨ä¹³è…ºç™Œç»†èƒä¸Šçš®é—´è´¨è½¬åŒ–è°ƒæ§ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283373" target="_blank" rel="noopener noreferrer">GSE283373 çŠ¬éº»ç–¹ç—…æ¯’æ„ŸæŸ“åŸä»£è‚ºæ³¡å·¨å™¬ç»†èƒçš„ç ”ç©¶æ­ç¤ºäº†ç—…æ¯’å¹²æ‰°å…ˆå¤©å…ç–«â€‹â€‹é˜²å¾¡ååº”çš„æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215255" target="_blank" rel="noopener noreferrer">GSE215255 å¯¹é‡ç”Ÿå‹å’Œ Sucnr1 åŸºå› æ•²é™¤å°é¼ éª¨é«“ä¸­ç» FACS åˆ†é€‰çš„é€ è¡€å¹²ç»†èƒå’Œç¥–ç»†èƒ (LSK) è¿›è¡Œ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309153" target="_blank" rel="noopener noreferrer">GSE309153 RNA-seq åˆ†æï¼Œç”¨äº 5â€™ isomiR è½¬æŸ“åçš„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309116" target="_blank" rel="noopener noreferrer">GSE309116 ç¼ºæ°§é©±åŠ¨çš„ç»„è›‹ç™½ä¿®é¥°æ§åˆ¶æˆç†Ÿçœ¼æ™¶çŠ¶ä½“å½¢æˆçš„åŸºå› è°ƒæ§ [CUT&amp;Run]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309107" target="_blank" rel="noopener noreferrer">GSE309107 ç¼ºæ°§é©±åŠ¨çš„ç»„è›‹ç™½ä¿®é¥°è°ƒæ§æˆç†Ÿçœ¼æ™¶çŠ¶ä½“å½¢æˆçš„åŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307095" target="_blank" rel="noopener noreferrer">GSE307095 RNA-seq åˆ†æé™æ¯å¹¼ç¨š B ç»†èƒå’Œ CD27bright è®°å¿† B ç»†èƒä»¥åŠä½“å¤–æ¿€æ´»çš„ CD27bright è®°å¿† B ç»†èƒï¼Œæ­ç¤ºäº†å¸¸è§å˜å¼‚å‹å…ç–«ç¼ºé™· (CVID) ä¸­ B ç»†èƒæ´»åŒ–æ¨¡å¼çš„å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305081" target="_blank" rel="noopener noreferrer">GSE305081 TET3 æ˜¯ä¸€ç§è°ƒèŠ‚å› å­ï¼Œå¯ä½œä¸ºå¹²é¢„å¿ƒè‚Œçº¤ç»´åŒ–çš„é¶ç‚¹ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305022" target="_blank" rel="noopener noreferrer">GSE305022 3D-ASC-Exos ä½œä¸ºä¸€ç§æ–°å‹è¯ç‰©è½½ä½“ç”¨äºèƒ¶è´¨ç˜¤æ²»ç–—</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304154" target="_blank" rel="noopener noreferrer">GSE304154 çŸ­æœŸå’Œé•¿æœŸé«˜è„‚é¥®é£Ÿä¸‹é¸¡çš„å¿«ç³–é…µè§£å‹å’Œæ…¢æ°§åŒ–å‹è‚Œçº¤ç»´çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303510" target="_blank" rel="noopener noreferrer">GSE303510 æ°´ç¨»ä¸­å…‰å“åº”æŸ“è‰²è´¨å¯åŠæ€§å›¾è°±[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302977" target="_blank" rel="noopener noreferrer">GSE302977 TET3 æ˜¯ä¸€ç§è°ƒèŠ‚å› å­ï¼Œå¯ä½œä¸ºå¹²é¢„å¿ƒè‚Œçº¤ç»´åŒ–çš„é¶ç‚¹ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302976" target="_blank" rel="noopener noreferrer">GSE302976 TET3 æ˜¯ä¸€ç§è°ƒèŠ‚å› å­ï¼Œå¯ä½œä¸ºå¹²é¢„å¿ƒè‚Œçº¤ç»´åŒ–çš„é¶ç‚¹ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301888" target="_blank" rel="noopener noreferrer">GSE301888 UBE2S å¯¹ç»“ç›´è‚ ç™Œç»†èƒç³» RKO çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301166" target="_blank" rel="noopener noreferrer">GSE301166 PURPL åŒå‘æ§åˆ¶è¡°è€ï¼šPURPL ç¼ºå¤±å¯ä½¿æˆçº¤ç»´ç»†èƒæ¢å¤æ´»åŠ›ï¼Œè€Œè¿‡è¡¨è¾¾åˆ™åŠ é€Ÿè¡°è€ [RNA-Seq2]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301164" target="_blank" rel="noopener noreferrer">GSE301164 å¤åˆ¶æ€§è¡°è€å’Œé˜¿éœ‰ç´ è¯±å¯¼è¡°è€çš„æ¯”è¾ƒåˆ†æé‰´å®šå‡ºè¡°è€æˆçº¤ç»´ç»†èƒä¸­ä¿å®ˆçš„è½¬å½•ç»„ç‰¹å¾ [RNA-Seq1]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300470" target="_blank" rel="noopener noreferrer">GSE300470 å¹²ç»†èƒå’Œç¥–ç»†èƒè¡ç”Ÿçš„åŸºå› è¡¨è¾¾ç‰¹å¾å¯é¢„æµ‹éª¨é«“çº¤ç»´åŒ–æ‚£è€…çš„ç”Ÿå­˜ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297417" target="_blank" rel="noopener noreferrer">GSE297417 å¯¹è‰¯æ€§å‰åˆ—è…ºå¢ç”Ÿæ¨¡å‹å°é¼ å’Œæ²»ç–—ç»„çš„å‰åˆ—è…ºç»„ç»‡è¿›è¡Œæ‰¹é‡ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297341" target="_blank" rel="noopener noreferrer">GSE297341 ç™Œç—‡æ²»ç–—å¯¹è‚ºç±»å™¨å®˜çš„å½±å“ä½œä¸ºåˆé€‚çš„ä½“å¤–æ¨¡å‹ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297024" target="_blank" rel="noopener noreferrer">GSE297024 é±¼ç²¾è›‹ç™½åœ¨ä½“ç»†èƒä¸­çš„è¡¨è¾¾ä¼šä½¿æŸ“è‰²è´¨æµ“ç¼©å¹¶ç ´åè½¬å½•ï¼Œä½†ä¸æ”¹å˜DNAç”²åŸºåŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296730" target="_blank" rel="noopener noreferrer">GSE296730 é±¼ç²¾è›‹ç™½åœ¨ä½“ç»†èƒä¸­çš„è¡¨è¾¾ä¼šä½¿æŸ“è‰²è´¨æµ“ç¼©å¹¶ç ´åè½¬å½•ï¼Œä½†ä¸æ”¹å˜DNAç”²åŸºåŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296164" target="_blank" rel="noopener noreferrer">GSE296164 ç ”ç©¶æ˜¾ç¤ºï¼Œéª¨é«“å’Œè¡€æ¶²è¡¨ç°å‡ºä¸åŒçš„å…ç–«é‡å»ºæ¨¡å¼ï¼Œå¹¶ä¸”ä¸ç§»æ¤åå¤å‘ç›¸å…³ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295535" target="_blank" rel="noopener noreferrer">GSE295535 Hfq åœ¨é²æ›¼ä¸åŠ¨æ†èŒä¸­æ„å»ºäº†ä¸€ä¸ªå¼ºå¤§çš„ RNA-RNA ç›¸äº’ä½œç”¨ç½‘ç»œã€‚[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295031" target="_blank" rel="noopener noreferrer">GSE295031 CAR NKç»†èƒçš„äº§ç”Ÿå¯é€šè¿‡åˆºæ¿€NKç¥–ç»†èƒä¸Šçš„IL15å—ä½“è€Œå¢å¼ºã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293219" target="_blank" rel="noopener noreferrer">GSE293219 è„‚è‚ªç»†èƒç‰¹å¼‚æ€§ Mlkl æ•²é™¤é€šè¿‡å¢å¼ºçº¿ç²’ä½“åŠŸèƒ½å‡è½»è‚¥èƒ–å¼•èµ·çš„ä»£è°¢åŠŸèƒ½éšœç¢ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291078" target="_blank" rel="noopener noreferrer">GSE291078 æ²™çœ¼è¡£åŸä½“æ„ŸæŸ“çš„åŸä»£å®«é¢ˆå†…è†œç»†èƒçš„ä»£è°¢é‡ç¼–ç¨‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290202" target="_blank" rel="noopener noreferrer">GSE290202 FAM49B é€šè¿‡è°ƒèŠ‚ MAPK ä¿¡å·é€šè·¯æŠ‘åˆ¶åµå·¢ç™Œç»†èƒç”Ÿé•¿</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289512" target="_blank" rel="noopener noreferrer">GSE289512 LINC01198 é€šè¿‡ä¸ TAOK1/2 ç»“åˆæ¿€æ´» Hippo ä¿¡å·é€šè·¯ï¼Œåˆºæ¿€ IL-1Î² è‡ªåˆ†æ³Œï¼Œä»è€Œå¢å¼ºé»‘è‰²ç´ ç˜¤å¯¹ç»´è«éå°¼çš„è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289136" target="_blank" rel="noopener noreferrer">GSE289136 ä¹³é…¸ä»‹å¯¼çš„ç»„è›‹ç™½ä¹³é…¸åŒ–ä¿ƒè¿›é»‘è‰²ç´ ç˜¤è¡€ç®¡ç”Ÿæˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288799" target="_blank" rel="noopener noreferrer">GSE288799 å°é¼ æ™šæœŸèƒšèƒè‚¾è„Kdr-FACSç»†èƒçš„å•æ ¸RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288442" target="_blank" rel="noopener noreferrer">GSE288442 æ¯ä½“äº§åä¹…åç”Ÿæ´»æ–¹å¼ä¼šåŠ å‰§é›„æ€§å°é¼ æ‘„å…¥ä¸­ç­‰è„‚è‚ªå«é‡é¥®é£Ÿçš„ä»£è°¢æˆæœ¬</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288424" target="_blank" rel="noopener noreferrer">GSE288424 CD271 é€šè¿‡ PI3K/Akt å’Œ PKCÎ±/ERK é€šè·¯è°ƒæ§çš®è‚¤ç»“æ„ã€åˆ†åŒ–å’Œç‚ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288262" target="_blank" rel="noopener noreferrer">GSE288262 Bç»†èƒç‰¹å¼‚æ€§WwoxåŸºå› ç¼ºå¤±ä¿ƒè¿›éª¨é«“ç˜¤å°é¼ æ¨¡å‹ä¸­æµ†æ¯ç»†èƒè‚¿ç˜¤çš„å‘ç”Ÿå‘å±•å’Œä¿ƒç‚ç‰¹å¾çš„è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288242" target="_blank" rel="noopener noreferrer">GSE288242 ç‰©ç§ç‰¹å¼‚æ€§è°ƒæ§å¤åˆç‰©å¡‘é€ é‡ç”Ÿç•ªèŒ„å¯¹åæ­»æ€§ç—…åŸä½“çš„å®šé‡æŠ—æ€§ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287898" target="_blank" rel="noopener noreferrer">GSE287898 é›„æ¿€ç´ è°ƒæ§çš„ECDè¿‡è¡¨è¾¾é€šè¿‡å¢åŠ ç³–é…µè§£ä¿ƒè¿›å‰åˆ—è…ºç™Œçš„è‚¿ç˜¤å‘ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286188" target="_blank" rel="noopener noreferrer">GSE286188 å…¨è½¬å½•ç»„æ•´åˆå…³è”åˆ†ææ­ç¤º FXTAS ä¸­ PRKCG ç›¸å…³çš„ GABA èƒ½åŠŸèƒ½éšœç¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285723" target="_blank" rel="noopener noreferrer">GSE285723 è‡­æ°§è¯±å¯¼å“®å–˜æ€¥æ€§å‘ä½œå°é¼ æ¨¡å‹è‚ºç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285283" target="_blank" rel="noopener noreferrer">GSE285283 è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒæ¥æºçš„ CD8+ å…‹éš†å‹æµ¸æ¶¦è‚¿ç˜¤ç»„ç»‡å¹¶ä»‹å¯¼èƒ¶è´¨æ¯ç»†èƒç˜¤çš„è‚¿ç˜¤æ¶ˆé€€ [WES]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285282" target="_blank" rel="noopener noreferrer">GSE285282 è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒæ¥æºçš„ CD8+ å…‹éš†å‹æµ¸æ¶¦è‚¿ç˜¤ç»„ç»‡å¹¶ä»‹å¯¼èƒ¶è´¨æ¯ç»†èƒç˜¤çš„è‚¿ç˜¤æ¶ˆé€€ [TCR]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282871" target="_blank" rel="noopener noreferrer">GSE282871 ç³–çš®è´¨æ¿€ç´ å—ä½“çš„å¤šèšåŒ–é€”å¾„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282307" target="_blank" rel="noopener noreferrer">GSE282307 Hutchinson-Gilfordæ—©è¡°ç—‡ä¸­çš„miRNAå¤±è°ƒï¼šæ­ç¤ºmiRNAä¸æ­£å¸¸è¡°è€å’Œè¿‡æ—©è¡°è€ä¹‹é—´çš„è”ç³»ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282029" target="_blank" rel="noopener noreferrer">GSE282029 å¤šç»„å­¦åˆ†ææ•´åˆæ­ç¤ºäº†ç»“è‚ ç™Œä¸­ä¸€ç§æ–°çš„ TRF2-miR-181a-5p-S100A10 è°ƒæ§è½´ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280863" target="_blank" rel="noopener noreferrer">GSE280863 ç ”ç©¶å‘ç°ï¼ŒSIRT5 ç¼ºå¤±ä¼šé€šè¿‡å˜Œå‘¤å’Œå˜§å•¶ä»£è°¢ç´Šä¹±åŠ é€Ÿå‹åŠ›è¶…è´Ÿè·è¯±å‘çš„å¿ƒåŠ›è¡°ç«­çš„å‘ç”Ÿå‘å±•ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280820" target="_blank" rel="noopener noreferrer">GSE280820 é€ è¡€é˜¶æ®µè¡¨è§‚é—ä¼ è°±åˆ†æé‰´å®šå‡ºæ„ŸæŸ“åå…·æœ‰ä¿å®ˆæŸ“è‰²è´¨æ”¹å˜çš„åŸºå› ç»„ä½ç‚¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274579" target="_blank" rel="noopener noreferrer">GSE274579 RPL6 ä¸ HMGCS1 ç›¸äº’ä½œç”¨ï¼Œé€šè¿‡æ¿€æ´»èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆæ¥ç¨³å®šè‚ç»†èƒç™Œ II ä¸­çš„ HIF-1Î±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274574" target="_blank" rel="noopener noreferrer">GSE274574 RPL6 ä¸ HMGCS1 ç›¸äº’ä½œç”¨ï¼Œé€šè¿‡æ¿€æ´»è‚ç»†èƒç™Œä¸­çš„èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆæ¥ç¨³å®š HIF-1Î±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273701" target="_blank" rel="noopener noreferrer">GSE273701 åˆ©ç”¨å•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºè™çš®é¹¦é¹‰è„¾è„ç™½ç»†èƒç¾¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253245" target="_blank" rel="noopener noreferrer">GSE253245 PACTåŸºå› æ•²é™¤å¯¹LNCaPå‰åˆ—è…ºç™Œç»†èƒçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249822" target="_blank" rel="noopener noreferrer">GSE249822 OTUD1 é€šè¿‡å»æ³›ç´ åŒ– STAT3 ä¸‹è°ƒ PD-L1 è¡¨è¾¾å¹¶ä¿ƒè¿› ccRCC ä¸­çš„å…ç–«ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228550" target="_blank" rel="noopener noreferrer">GSE228550 é€šè¿‡æŠ‘åˆ¶p38Î±é€†è½¬é«“ç³»æ¥æºæŠ‘åˆ¶ç»†èƒä»‹å¯¼çš„å…ç–«æŠ‘åˆ¶å¯å¢å¼ºå…ç–«ç–—æ³•çš„ç–—æ•ˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224497" target="_blank" rel="noopener noreferrer">GSE224497 é€šè¿‡å·¥ç¨‹æ”¹é€ æ ¸å¼¹æ€§æ¥æ“æ§ä½“ç»†èƒå‘½è¿ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224496" target="_blank" rel="noopener noreferrer">GSE224496 é€šè¿‡å·¥ç¨‹æ”¹é€ æ ¸å¼¹æ€§æ¥æ“æ§ä½“ç»†èƒå‘½è¿ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312139" target="_blank" rel="noopener noreferrer">GSE312139 è¶…è¶ŠÎ²-æ·€ç²‰æ ·è›‹ç™½å’Œtauè›‹ç™½ï¼šä¸€ç§åŸºäºç»†èƒçš„å¤šå˜é‡è¡€æ¶²æ£€æµ‹ï¼ˆiCAPï¼‰ç”¨äºæ—©æœŸé˜¿å°”èŒ¨æµ·é»˜ç—…æ£€æµ‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305560" target="_blank" rel="noopener noreferrer">GSE305560 TP53æ— å…³è‡´æ­»æ€§ï¼šé€šè¿‡è”åˆæ³›HDACå’ŒCDKæŠ‘åˆ¶æ²»ç–—æ€¥æ€§é«“ç³»ç™½è¡€ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297637" target="_blank" rel="noopener noreferrer">GSE297637 STING è¯±å¯¼çš„ç¨‹åºæ€§åæ­»è°ƒèŠ‚è„‘è†œç˜¤ä¸­å¯Œå«èƒ¶åŸè›‹ç™½çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295763" target="_blank" rel="noopener noreferrer">GSE295763 åˆ©ç”¨ CRISPR/Cas9 æŠ€æœ¯ç²¾ç¡®åˆ‡é™¤ NOTCH2NLC ä¸­æ‰©å¢çš„ GGC é‡å¤åºåˆ—ä»¥æ²»ç–—ç¥ç»å…ƒæ ¸å†…åŒ…æ¶µä½“ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284354" target="_blank" rel="noopener noreferrer">GSE284354 ä¸¤ç§è½¬åŒ–æ€§HFpEFå°é¼ æ¨¡å‹ä¸­å…´å¥‹-æ”¶ç¼©è€¦è”ã€å¿ƒè‚Œç»†èƒç”µç”Ÿç†å’Œè½¬å½•ç»„çš„å˜åŒ–ï¼šç—…å› å’Œæ€§åˆ«å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283707" target="_blank" rel="noopener noreferrer">GSE283707 æ˜¼å¤œç³–åŸä»£è°¢é©±åŠ¨è‚è„è›‹ç™½è´¨èŠ‚å¾‹æ€§åˆ†æ³Œ[ä½“å†…]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283579" target="_blank" rel="noopener noreferrer">GSE283579 æ˜¼å¤œç³–åŸä»£è°¢é©±åŠ¨è‚è„è›‹ç™½è´¨èŠ‚å¾‹æ€§åˆ†æ³Œ[ä½“å¤–]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271844" target="_blank" rel="noopener noreferrer">GSE271844 åˆ©ç”¨D-ç²¾æ°¨é…¸å¢å¼ºæŠ‘åˆ¶è‚½ï¼Œä»¥æé«˜å…¶ç»“æ„ç¨³å®šæ€§å’Œå¯¹è‚¥èƒ–çš„ä½“å†…ä»£è°¢ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312238" target="_blank" rel="noopener noreferrer">GSE312238 åˆ©ç”¨ CHANGE-seq-BE å¯¹ç¢±åŸºç¼–è¾‘å™¨è¯±å¯¼çš„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„å…¨åŸºå› ç»„åˆ†æ [Digenome-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311868" target="_blank" rel="noopener noreferrer">GSE311868 éå°ç»†èƒè‚ºç™Œä¸­çº¿ç²’ä½“åŒé“¾RNAä¾èµ–æ€§è„‚è´¨é‡ç¼–ç¨‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306352" target="_blank" rel="noopener noreferrer">GSE306352 c-di-AMPâ€“DasR ä¿¡å·è½´ä»‹å¯¼åˆ†ææ†èŒçš„è€é…¸æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279970" target="_blank" rel="noopener noreferrer">GSE279970 ChIP-seq åˆ†æè‚è„ç¼ºè¡€å†çŒæ³¨æŸä¼¤ä¸­ LIF ä¿¡å·ä¸‹æ¸¸çš„ STAT3 é¶åŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260956" target="_blank" rel="noopener noreferrer">GSE260956 è‚è„ GPNMB é€šè¿‡ä¸ RYK ç»“åˆåŠ å‰§ NASH [RNA-Seq]</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-03 21:33</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>